Dr-gmaker Emergent BioSolutions said on Monday that it would reduce its workforce in Lansing, Michigan, by up to 70 roles as part of its ongoing restructuring efforts.
The Gaithersburg, Maryland-based company has been cutting costs and pivoting away from its contract manufacturing business due to sluggish demand and a focus on driving sales growth for its opi--d overdose reversal dr-g Narcan and other branded dr-gs.
In May, Emergent cut about 300 jobs and shut down a dr-g substance manufacturing facility in Baltimore, Bayview and a dr-g product facility in Rockville, Maryland.
https://www.reuters.com/business/healthcare-pharmaceuticals/emergent-cut-up-70-roles-lansing-facility-2024-08-26/